Chris dissects 23andMe’s bankruptcy—great concept, no repeat business. Once valued at $6B, it’s now a cautionary tale: one-off DNA tests don’t sustain a company. Wall Street cashed in, but the well’s dry. Protect your data! www.watchdogonwallstreet.com